~50 spots leftby Oct 2026

Motivational Interviewing for Substance Use Disorders

Recruiting in Palo Alto (17 mi)
Overseen ByMargo Hurlocker, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of New Mexico
Disqualifiers: Severe withdrawal, Psychotic, Manic, Suicidal
No Placebo Group

Trial Summary

What is the purpose of this trial?This trial is testing if a special way of talking to patients when they start addiction treatment can help them stay engaged. The method involves counselors helping patients find their own reasons for wanting to change.
Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, since participants must be physically withdrawn from alcohol or other drugs, you might need to stop using substances related to your addiction.

What data supports the effectiveness of the treatment Motivational Interviewing for Substance Use Disorders?

Motivational Interviewing (MI) is shown to be effective in promoting change in problematic alcohol and drug use by helping clients explore and resolve ambivalence (mixed feelings). It is a client-centered approach that aims to increase motivation and commitment to change, although its effectiveness can vary among individuals.

12345
Is Motivational Interviewing safe for humans?

Motivational Interviewing (MI) is generally considered safe as it is a client-centered approach that focuses on enhancing motivation and commitment to change in a supportive and compassionate environment. It has been used in various settings without reports of harm, indicating it is safe for human use.

12456
How is Motivational Interviewing at Intake (MII) different from other treatments for substance use disorders?

Motivational Interviewing at Intake (MII) is unique because it focuses on enhancing a person's own motivation to change by exploring their reasons for change and resolving mixed feelings in a supportive environment, rather than directly instructing them on what to do.

12578

Eligibility Criteria

This trial is for English-speaking adults seeking outpatient treatment for alcohol or drug use, who are willing to follow study procedures and have given informed consent. It's also open to staff at the treatment programs. Participants must not be physically dependent on substances at the time of intake.

Exclusion Criteria

I am not experiencing severe mental health issues like psychosis, mania, or suicidal thoughts.
Current position: facility owner or clinical director
Experiencing severe withdrawal symptoms

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intake

Participants undergo either a standard assessment or a Motivational Interviewing session at intake

1 session (90 minutes)
1 visit (in-person)

Treatment

Participants engage in a three-month outpatient treatment program

12 weeks
Multiple visits (in-person)

Follow-up

Participants are monitored for completion of the treatment program and engagement metrics

up to 36 weeks

Participant Groups

The study compares two approaches: usual intake procedures versus Motivational Interviewing at Intake (MII) to see which is more effective in engaging clients in addiction treatment. The trial will also assess how easy it is to integrate MII into regular practice.
2Treatment groups
Experimental Treatment
Active Control
Group I: Motivational Interviewing at Intake (MII)Experimental Treatment1 Intervention
Clients allocated to the MII condition will receive a 90-minute pure Motivational Interviewing (MI) session.
Group II: Intake as Usual (IAU)Active Control1 Intervention
Clients allocated to the IAU condition will receive the 90-minute standard assessment that is delivered to all clients entering intensive outpatient program (IOP)/outpatient program (OP).

Intake as Usual (IAU) is already approved in United States, European Union for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ Approved in United States as Intake as Usual for:
  • Addiction Treatment
  • Substance Use Disorders
๐Ÿ‡ช๐Ÿ‡บ Approved in European Union as Standard Intake for:
  • Addiction Treatment
  • Substance Use Disorders

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Turning Point Recovery CenterAlbuquerque, NM
Loading ...

Who Is Running the Clinical Trial?

University of New MexicoLead Sponsor
National Institute on Drug Abuse (NIDA)Collaborator

References

What can clients tell us about whether to use motivational interviewing? An analysis of early-session ambivalent language. [2023]Although motivational interviewing (MI) is an effective method for promoting change in problematic alcohol and other drug use, it does not benefit all clients. Clinicians have little empirical guidance on who is likely to benefit from MI and who is not. We hypothesized that differences in clients' spontaneously offered language early in the session would predict their responsiveness to MI during the remainder of the session.
Motivational interviewing in drug abuse services: a randomized trial. [2022]Motivational interviewing (MI) is a directive, client-centered brief intervention to elicit behavior change by helping clients explore and resolve ambivalence. In this clinical trial, 152 outpatients and 56 inpatients entering public agencies for treatment of drug problems were randomly assigned to receive or not receive a single session of manual-guided MI. Drug use was assessed by self-report, urine toxicology, and collateral reports from significant others at baseline, 3, 6, 9, and 12 months. Contrary to prior reports, MI showed no effect on drug use outcomes when added to inpatient or outpatient treatment, although both groups showed substantial increases in abstinence from illicit drugs and alcohol.
Motivational tools to improve probationer treatment outcomes. [2021]Motivational interviewing (MI) is a promising practice to increase motivation, treatment retention, and reducing recidivism among offender populations. Computer-delivered interventions have grown in popularity as a way to change behaviors associated with drug and alcohol use.
Effectiveness and feasibility of a motivational interviewing intake (MII) intervention for increasing client engagement in outpatient addiction treatment: an effectiveness-implementation hybrid design protocol. [2023]Client discontinuation from outpatient addiction treatment programs is common, and the initial intake is the service delivery point with the highest attrition rate. Replacing the comprehensive intake assessment with a person-centered Motivational Interviewing (MI) intervention is a potential solution to address provider and client concerns about the disengaging, time-intensive nature of the typical initial intake. It remains unclear whether the use of an alternative to the standard intake at the initial visit can fit within typical organizational reporting requirements, whether it decreases attrition, and whether implementation of person-centered intake procedures within outpatient addiction treatment programs is feasible, acceptable, and can be sustained.
Motivational interviewing for substance use reduction. [2023]Substance use is a global issue, with around 30 to 35 million individuals estimated to have a substance-use disorder. Motivational interviewing (MI) is a client-centred method that aims to strengthen a person's motivation and commitment to a specific goal by exploring their reasons for change and resolving ambivalence, in an atmosphere of acceptance and compassion. This review updates the 2011 version by Smedslund and colleagues.
A pilot test of motivational interviewing groups for dually diagnosed inpatients. [2019]Motivational interviewing is a brief treatment approach designed to produce rapid, internally motivated change in addictive behaviors. Motivational interviewing shows promise for engaging clients with dual psychiatric and psychoactive substance use diagnoses in treatment. While initially developed as an individual treatment approach, key motivational enhancement principles may be applied to structured group interventions to facilitate its introduction to inpatient dual-diagnosis treatment. We describe how we developed and pilot-tested a motivational interviewing group for dually diagnosed inpatients, and illustrate successes and pitfalls in clinical implementation. Group participants were readily engaged by the entertaining format and often provocative content, and appeared to benefit from exploration of their ambivalence regarding change. Directions for further development and evaluation are proposed.
Motivational interviewing for substance abuse. [2022]There are 76.3 million people with alcohol use disorders worldwide and 15.3 million with drug use disorders. Motivational interviewing (MI) is a client-centred, semi-directive method for enhancing intrinsic motivation to change by exploring and resolving ambivalence. The intervention is used widely, and therefore it is important to find out whether it helps, harms or is ineffective.
After 30 years of dissemination, have we achieved sustained practice change in motivational interviewing? [2022]Motivational interviewing (MI) is the most successfully disseminated evidence-based practice in the substance use disorder (SUD) treatment field. This systematic review considers two questions relevant to policymakers and service providers: (1) does training in MI achieve sustained practice change in clinicians delivering SUD treatment; and (2) do clinicians achieve a level of competence after training in MI that impacts upon client outcomes?